This conserved pattern across multiple tumour types underscores the therapeutic potential of targeting the WWOX/HIF1A axis to reprogram tumour metabolism, restrict malignancy and disrupt metastatic progression, and improve clinical outcomes, although further research is warranted to fully elucidate the context-dependent effects observed across different tumour subtypes. The gene discussed is HIF1A; the disease is neoplasm.